Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4760290
Max Phase: Preclinical
Molecular Formula: C51H59ClN3O9P
Molecular Weight: 889.02
Molecule Type: Unknown
Associated Items:
ID: ALA4760290
Max Phase: Preclinical
Molecular Formula: C51H59ClN3O9P
Molecular Weight: 889.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H]1c2ccc(NC(=O)CCCCCCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)c(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Cl-]
Standard InChI: InChI=1S/C51H58N3O9P.ClH/c1-31-35-28-29-36(44(56)39(35)45(57)40-38(31)46(58)42-43(54(2)3)47(59)41(50(52)62)49(61)51(42,63)48(40)60)53-37(55)27-19-8-6-4-5-7-9-20-30-64(32-21-13-10-14-22-32,33-23-15-11-16-24-33)34-25-17-12-18-26-34;/h10-18,21-26,28-29,31,38,42-43,46,58,63H,4-9,19-20,27,30H2,1-3H3,(H5-,52,53,55,56,57,59,60,61,62);1H/t31-,38+,42+,43-,46-,51-;/m0./s1
Standard InChI Key: LETKLPVHNAWHOE-YMXJSRHDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 889.02 | Molecular Weight (Monoisotopic): 888.3983 | AlogP: 6.10 | #Rotatable Bonds: 17 |
Polar Surface Area: 210.72 | Molecular Species: ACID | HBA: 10 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 2.87 | CX Basic pKa: 7.78 | CX LogP: 3.90 | CX LogD: 3.41 |
Aromatic Rings: 4 | Heavy Atoms: 64 | QED Weighted: 0.03 | Np Likeness Score: 0.80 |
1. Cochrane EJ,Hulit J,Lagasse FP,Lechertier T,Stevenson B,Tudor C,Trebicka D,Sparey T,Ratcliffe AJ. (2021) Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells., 12 (4.0): [PMID:33859798] [10.1021/acsmedchemlett.0c00632] |
Source(1):